Researchers are developing quick-brew vaccines and ones that catch multiple strains of flu.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Understanding how the virus passes between mammals is a critical public health issue, they say.
The DARPA-funded advance is designed to keep soldiers alive long enough to reach a hospital.
Intestinal microbes from male mice changed the hormones and disease rates of female mice.
Researchers found they could tie people’s identities to supposedly anonymous genetic data by cross-referencing it with information available online.
Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.
A new study suggests that some of the hearing loss caused by noise exposure can be reversed with drugs.
A modification to existing LEDs based on firefly abdomens can boost the brightness of the light source.
Many new fitness-tracking devices are on display at the Consumer Electronics Show in Las Vegas.
It’s hard to get straightforward health guidance from personal genome tests, which are banned in some places. But one way to make them more meaningful is to let more people buy them.